Ignite Creation Date:
2024-05-06 @ 3:24 PM
Last Modification Date:
2024-10-26 @ 1:49 PM
Study NCT ID:
NCT04628871
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-05-03
First Post:
2020-11-09
Brief Title:
Long Term Follow-up LTFU of Subjects Who Received SB-318 SB-913 or SB-FIX
Sponsor:
Sangamo Therapeutics
Organization:
Sangamo Therapeutics
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Mucopolysaccharidosis II |
| Hemophilia B |
| Mucopolysaccharidosis I |
Keywords:
| Name | View |
|---|---|
| MPS | View |
| Mucopolysaccharidosis I | View |
| Hurler-Scheie Syndrome | View |
| Mucopolysaccharidosis II | View |
| Hunter Syndrome | View |
| Gene Editing | View |
| Gene Therapy | View |
| Zinc Finger | View |
| SB-318 | View |
| SB-913 | View |
| SB-FIX | View |
| Rare | View |
| Genetic | View |
| DNA | View |
| Sangamo | View |
| ZFN | View |
| Long Term | View |
| Hemophilia B | View |